drugset / Trial / NCT02965703

Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

NCT02965703

Phase 2 Active not recruiting 81 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindPrevention

Summary

This phase IIa trial studies how well aspirin works in preventing colorectal cancer in patients with colorectal adenoma. Aspirin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start
2018-01-16
Primary completion
2023-01-31
Completion
2026-12-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 325 mg Oral